Cargando…

DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()()

The purpose of this study was dual: to investigate (a) whether sunitinib may induce changes in tumor microvasculature and hypoxia in pancreatic ductal adenocarcinoma (PDAC) and (b) whether any changes can be detected by DCE-MRI. Sunitinib-treated and untreated control tumors of two PDAC xenograft mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wegner, Catherine S., Hauge, Anette, Simonsen, Trude G., Gaustad, Jon-Vidar, Andersen, Lise Mari K., Rofstad, Einar K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041378/
https://www.ncbi.nlm.nih.gov/pubmed/29886124
http://dx.doi.org/10.1016/j.neo.2018.05.006
_version_ 1783338982701006848
author Wegner, Catherine S.
Hauge, Anette
Simonsen, Trude G.
Gaustad, Jon-Vidar
Andersen, Lise Mari K.
Rofstad, Einar K.
author_facet Wegner, Catherine S.
Hauge, Anette
Simonsen, Trude G.
Gaustad, Jon-Vidar
Andersen, Lise Mari K.
Rofstad, Einar K.
author_sort Wegner, Catherine S.
collection PubMed
description The purpose of this study was dual: to investigate (a) whether sunitinib may induce changes in tumor microvasculature and hypoxia in pancreatic ductal adenocarcinoma (PDAC) and (b) whether any changes can be detected by DCE-MRI. Sunitinib-treated and untreated control tumors of two PDAC xenograft models (BxPC-3 and Panc-1) were subjected to DCE-MRI before the imaged tumors were prepared for quantitative analysis of immunohistochemical preparations. Pimonidazole was used as a hypoxia marker, and fraction of hypoxic tissue (HF(Pim)), density of CD31-positive microvessels (MVD(CD31)), and density of αSMA-positive microvessels (MVD(αSMA)) were measured. Parametric images of K(trans) and v(e) were derived from the DCE-MRI data by using the Tofts pharmacokinetic model. BxPC-3 tumors showed increased HF(Pim), decreased MVD(CD31), unchanged MVD(αSMA), and increased vessel maturation index (VMI = MVD(αSMA)/MVD(CD31)) after sunitinib treatment. The increase in VMI was seen because sunitinib induced selective pruning rather than maturation of αSMA-negative microvessels. Even though the microvessels in sunitinib-treated tumors were less abnormal than those in untreated tumors, this microvessel normalization did not improve the function of the microvascular network or normalize the tumor microenvironment. In Panc-1 tumors, HF(Pim), MVD(CD31), MVD(αSMA), and VMI were unchanged after sunitinib treatment. Median K(trans) increased with increasing MVD(CD31) and decreased with increasing HF(Pim), and the correlations were similar for treated and untreated BXPC-3 and Panc-1 tumors. These observations suggest that sunitinib may induce significant changes in the microenvironment of PDACs, and furthermore, that K(trans) may be an adequate measure of tumor vascular density and hypoxia in untreated as well as sunitinib-treated PDACs.
format Online
Article
Text
id pubmed-6041378
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-60413782018-07-13 DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()() Wegner, Catherine S. Hauge, Anette Simonsen, Trude G. Gaustad, Jon-Vidar Andersen, Lise Mari K. Rofstad, Einar K. Neoplasia Original article The purpose of this study was dual: to investigate (a) whether sunitinib may induce changes in tumor microvasculature and hypoxia in pancreatic ductal adenocarcinoma (PDAC) and (b) whether any changes can be detected by DCE-MRI. Sunitinib-treated and untreated control tumors of two PDAC xenograft models (BxPC-3 and Panc-1) were subjected to DCE-MRI before the imaged tumors were prepared for quantitative analysis of immunohistochemical preparations. Pimonidazole was used as a hypoxia marker, and fraction of hypoxic tissue (HF(Pim)), density of CD31-positive microvessels (MVD(CD31)), and density of αSMA-positive microvessels (MVD(αSMA)) were measured. Parametric images of K(trans) and v(e) were derived from the DCE-MRI data by using the Tofts pharmacokinetic model. BxPC-3 tumors showed increased HF(Pim), decreased MVD(CD31), unchanged MVD(αSMA), and increased vessel maturation index (VMI = MVD(αSMA)/MVD(CD31)) after sunitinib treatment. The increase in VMI was seen because sunitinib induced selective pruning rather than maturation of αSMA-negative microvessels. Even though the microvessels in sunitinib-treated tumors were less abnormal than those in untreated tumors, this microvessel normalization did not improve the function of the microvascular network or normalize the tumor microenvironment. In Panc-1 tumors, HF(Pim), MVD(CD31), MVD(αSMA), and VMI were unchanged after sunitinib treatment. Median K(trans) increased with increasing MVD(CD31) and decreased with increasing HF(Pim), and the correlations were similar for treated and untreated BXPC-3 and Panc-1 tumors. These observations suggest that sunitinib may induce significant changes in the microenvironment of PDACs, and furthermore, that K(trans) may be an adequate measure of tumor vascular density and hypoxia in untreated as well as sunitinib-treated PDACs. Neoplasia Press 2018-06-19 /pmc/articles/PMC6041378/ /pubmed/29886124 http://dx.doi.org/10.1016/j.neo.2018.05.006 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original article
Wegner, Catherine S.
Hauge, Anette
Simonsen, Trude G.
Gaustad, Jon-Vidar
Andersen, Lise Mari K.
Rofstad, Einar K.
DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()()
title DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()()
title_full DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()()
title_fullStr DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()()
title_full_unstemmed DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()()
title_short DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts()()
title_sort dce-mri of sunitinib-induced changes in tumor microvasculature and hypoxia: a study of pancreatic ductal adenocarcinoma xenografts()()
topic Original article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041378/
https://www.ncbi.nlm.nih.gov/pubmed/29886124
http://dx.doi.org/10.1016/j.neo.2018.05.006
work_keys_str_mv AT wegnercatherines dcemriofsunitinibinducedchangesintumormicrovasculatureandhypoxiaastudyofpancreaticductaladenocarcinomaxenografts
AT haugeanette dcemriofsunitinibinducedchangesintumormicrovasculatureandhypoxiaastudyofpancreaticductaladenocarcinomaxenografts
AT simonsentrudeg dcemriofsunitinibinducedchangesintumormicrovasculatureandhypoxiaastudyofpancreaticductaladenocarcinomaxenografts
AT gaustadjonvidar dcemriofsunitinibinducedchangesintumormicrovasculatureandhypoxiaastudyofpancreaticductaladenocarcinomaxenografts
AT andersenlisemarik dcemriofsunitinibinducedchangesintumormicrovasculatureandhypoxiaastudyofpancreaticductaladenocarcinomaxenografts
AT rofstadeinark dcemriofsunitinibinducedchangesintumormicrovasculatureandhypoxiaastudyofpancreaticductaladenocarcinomaxenografts